Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2019-11-08 Interim / Quarterly Rep…
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2019
2019-11-08 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes multiple items: Item 2.02 reports results of operations and financial condition for the quarter ended September 30, 2019, with a press release attached; Item 7.01 includes Regulation FD disclosure with a webcast conference call and prepared remarks attached; and an announcement of an acquisition agreement (Diversigen, Inc.). The document is not a full quarterly or annual report but a current report announcing financial results and other significant events. The presence of a press release announcing quarterly financial results and a conference call transcript suggests this is an Earnings Release (ER) filing. The acquisition announcement is also included but the primary focus is on quarterly results and guidance. Therefore, the best classification is Earnings Release (ER).
2019-11-06 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement for the sale of a business segment, completion of the sale, and related pro forma financial information. It also includes a press release and exhibits related to the transaction. This type of filing is typically categorized as a Regulatory Filing (RNS) because it is a current report disclosing material events, not a full annual or quarterly report, nor a specific category like M&A filings or earnings releases. The document length is 7869 characters, which is consistent with a detailed 8-K filing. Therefore, the best classification is Regulatory Filings (RNS).
2019-08-19 English
PRIMARY DOCUMENT
Director's Dealing
2019-08-14 English
PRIMARY DOCUMENT
Director's Dealing
2019-08-14 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the appointment of a new director, amendments to the director compensation policy, and an amendment to the company's Code of Ethics. These topics relate to changes in the company's board and management, as well as governance practices. There are no financial statements or detailed financial results presented, so it is not an Annual Report, Interim Report, or Earnings Release. The primary focus is on board and management changes and governance updates. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2019-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.